Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
about
Abnormal PTPN11 enhancer methylation promotes rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and joint inflammationBeyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.Targeting Tyrosine Phosphatases: Time to End the Stigma.Site-specific identification of heparan and chondroitin sulfate glycosaminoglycans in hybrid proteoglycans.Suppressive Effects of TSAHC in an Experimental Mouse Model and Fibroblast-Like Synoviocytes of Rheumatoid Arthritis.
P2860
Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
@en
type
label
Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
@en
prefLabel
Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
@en
P2093
P2860
P50
P1476
Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.
@en
P2093
A Radu Aricescu
Beatrix Bartok
Camille Fos
Cristiano Sacchetti
David L Boyle
Esther Cory
Gary S Firestein
Heather A Arnett
Jeffrey D Esko
Karen M Doody
P2860
P304
P356
10.1126/SCITRANSLMED.AAA4616
P407
P577
2015-05-01T00:00:00Z